|
Volumn 7, Issue 2, 2006, Pages 107-
|
Intraperitoneal treatment lengthens survival in ovarian cancer
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
PACLITAXEL;
ABDOMINAL PAIN;
ADVANCED CANCER;
CANCER STAGING;
CANCER SURVIVAL;
CLINICAL TRIAL;
CYTOREDUCTIVE SURGERY;
DRUG EFFICACY;
DRUG MEGADOSE;
DRUG PENETRATION;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
FEMALE;
HUMAN;
NOTE;
OVARY CANCER;
PERITONEAL CATHETER;
PRIORITY JOURNAL;
SIDE EFFECT;
TUMOR VOLUME;
ANTINEOPLASTIC AGENTS;
FEMALE;
HUMANS;
INFUSIONS, INTRAVENOUS;
INFUSIONS, PARENTERAL;
OVARIAN NEOPLASMS;
|
EID: 31544438847
PISSN: 14702045
EISSN: None
Source Type: Journal
DOI: 10.1016/S1470-2045(06)70557-5 Document Type: Note |
Times cited : (2)
|
References (0)
|